These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1687761)

  • 1. Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):733-7. PubMed ID: 1687761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
    Young R; Johnson DN
    Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fully automated light/dark apparatus useful for comparing anxiolytic agents.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):739-43. PubMed ID: 1687762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
    Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
    Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
    Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
    Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    King GL
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.
    Andrews N; File SE
    Eur J Pharmacol; 1993 Apr; 235(1):109-12. PubMed ID: 8519271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
    King GL; Landauer MR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1026-33. PubMed ID: 2359014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
    File SE; Johnston AL
    Psychopharmacology (Berl); 1989; 99(2):248-51. PubMed ID: 2552485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
    Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
    Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
    Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
    Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
    Ruhland M; Krähling H; Fuchs A; Schön U
    Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of serotonergic agents on isolation-induced aggression.
    White SM; Kucharik RF; Moyer JA
    Pharmacol Biochem Behav; 1991 Jul; 39(3):729-36. PubMed ID: 1686105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.
    Bill DJ; Fletcher A; Glenn BD; Knight M
    Eur J Pharmacol; 1992 Aug; 218(2-3):327-34. PubMed ID: 1358637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.